BiOkuris Newsroom
Explore our recent announcements, media coverage, and expert analyses to stay informed about our ongoing efforts to innovate and provide effective solutions for those affected by gastrointestinal conditions. Here, we share our progress, from pre-clinical developments and clinical trials to our achievements in bringing our commercial products to the people who need them most.
Stay connected with BiOkuris on Linkedin
26/03/2024 : First patient enrolled in our relieve study!
03/04/2024 : BiOkuris is nominated as a finalist for the NutraIngredients Awards!
06/05/2024 : BiOkuris’ lastest paper on chitin-glucan
07/05/2024 : ISO 9001
15/05/2024 : BiOkuris’ chitin glucan has won the jurys award of the most sustainable ingredient!
28/05/2024: Our first clinical paper on BK001
07-10/09/2024 : BiOkuris at the 46th ESPEN Congress in Milan.
12-13/09/2024 : BiOkuris is at Pharmasynergy in Paris on 12 and 13 September.
23/09/20024 : Our fungal chitin-glucan is now Monash University Low FODMAP Certified™!
25/09/2024 : Good news for IBS patients… The investigator meeting of Vitabiotic study
08-10/10/2024: BiOkuris is excited to attend CPHI in Milan.
11-15/10/2024: BiOkuris is excited to share that Prof. Edouard Louis will present our poster at UEG Week